Jaguar health receives additional 180-day grace period to regain compliance with nasdaq's bid price rule

San francisco, ca / accesswire / august 19, 2022 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that on august 18, 2022 the company received formal notice that the listing qualifications staff of the nasdaq stock market llc has granted jaguar an additional 180-day grace period, through february 13, 2023, to regain compliance with the $1.00 bid price requirement for continued listing on the nasdaq capital market. to evidence compliance, the company must report a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days on or before february 13, 2023.
JAGX Ratings Summary
JAGX Quant Ranking